Flatiron Health, Foundation Medicine, and Genentech have launched the Prospective Clinico-Genomic (PCG) feasibility study. The trial will pilot the use of a technology-enabled prospective data collection platform to facilitate, streamline, and...
The collaboration will leverage advanced analytical techniques to answer questions about the use of diagnostics and medications in the pandemic, and risk factors for coronavirus-related complications in different patient populations.
The Irvine, CA-based company said its Pascal System has not yet been approved in the U.S.
The collaboration will help support return-to-workplace planning for employers and employees.
Pressed for time? Here's the medtech news you need most, in one minute or less. Now available as a micro-podcast.